rs5626

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000961.4(PTGIS):​c.706C>T​(p.Arg236Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00149 in 1,614,158 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R236L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0078 ( 14 hom., cov: 32)
Exomes 𝑓: 0.00083 ( 9 hom. )

Consequence

PTGIS
NM_000961.4 missense

Scores

4
14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.56

Publications

13 publications found
Variant links:
Genes affected
PTGIS (HGNC:9603): (prostaglandin I2 synthase) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. However, this protein is considered a member of the cytochrome P450 superfamily on the basis of sequence similarity rather than functional similarity. This endoplasmic reticulum membrane protein catalyzes the conversion of prostglandin H2 to prostacyclin (prostaglandin I2), a potent vasodilator and inhibitor of platelet aggregation. An imbalance of prostacyclin and its physiological antagonist thromboxane A2 contribute to the development of myocardial infarction, stroke, and atherosclerosis. [provided by RefSeq, Jul 2008]
PTGIS Gene-Disease associations (from GenCC):
  • essential hypertension, genetic
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010237157).
BP6
Variant 20-49524207-G-A is Benign according to our data. Variant chr20-49524207-G-A is described in ClinVar as Benign. ClinVar VariationId is 781903.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00783 (1193/152304) while in subpopulation AFR AF = 0.0269 (1118/41564). AF 95% confidence interval is 0.0256. There are 14 homozygotes in GnomAd4. There are 545 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTGISNM_000961.4 linkc.706C>T p.Arg236Cys missense_variant Exon 6 of 10 ENST00000244043.5 NP_000952.1 Q16647

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTGISENST00000244043.5 linkc.706C>T p.Arg236Cys missense_variant Exon 6 of 10 1 NM_000961.4 ENSP00000244043.3 Q16647
PTGISENST00000478971.1 linkn.527C>T non_coding_transcript_exon_variant Exon 5 of 9 1

Frequencies

GnomAD3 genomes
AF:
0.00783
AC:
1192
AN:
152186
Hom.:
14
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0270
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00314
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.00430
GnomAD2 exomes
AF:
0.00197
AC:
496
AN:
251358
AF XY:
0.00141
show subpopulations
Gnomad AFR exome
AF:
0.0261
Gnomad AMR exome
AF:
0.00127
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000176
Gnomad OTH exome
AF:
0.000815
GnomAD4 exome
AF:
0.000830
AC:
1213
AN:
1461854
Hom.:
9
Cov.:
33
AF XY:
0.000696
AC XY:
506
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.0260
AC:
870
AN:
33480
American (AMR)
AF:
0.00154
AC:
69
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53386
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.000132
AC:
147
AN:
1112010
Other (OTH)
AF:
0.00187
AC:
113
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
78
156
234
312
390
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00783
AC:
1193
AN:
152304
Hom.:
14
Cov.:
32
AF XY:
0.00732
AC XY:
545
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0269
AC:
1118
AN:
41564
American (AMR)
AF:
0.00314
AC:
48
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10620
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000191
AC:
13
AN:
68020
Other (OTH)
AF:
0.00426
AC:
9
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
56
111
167
222
278
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00273
Hom.:
13
Bravo
AF:
0.00876
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0284
AC:
125
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00242
AC:
294
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.38
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.43
T
Eigen
Uncertain
0.30
Eigen_PC
Benign
0.22
FATHMM_MKL
Benign
0.48
N
LIST_S2
Uncertain
0.92
D
MetaRNN
Benign
0.010
T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
1.9
L
PhyloP100
2.6
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.8
N
REVEL
Benign
0.13
Sift
Benign
0.17
T
Sift4G
Benign
0.17
T
Polyphen
1.0
D
Vest4
0.34
MVP
0.86
MPC
0.14
ClinPred
0.032
T
GERP RS
4.3
Varity_R
0.26
gMVP
0.44
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5626; hg19: chr20-48140744; COSMIC: COSV54836743; API